Article Information
History
- November 24, 2021.
Article Versions
- Version 1 (October 26, 2021 - 16:25).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Elsa Lorthe1,a,*,
- Mathilde Bellon2,3,a,
- Grégoire Michielin4,
- Julie Berthelot1,
- María-Eugenia Zaballa1,
- Francesco Pennacchio1,
- Meriem Bekliz2,
- Florian Laubscher5,
- Fatemeh Arefi4,
- Javier Perez-Saez1,6,
- Andrew S Azman1,6,7,
- Arnaud G L’Huillier5,8,
- Klara M Posfay-Barbe8,
- Laurent Kaiser3,9,
- Idris Guessous10,11,
- Sebastian Maerkl4,
- Isabella Eckerle2,3,5,9,b,
- Silvia Stringhini1,11,12,b and
- on behalf of the SEROCoV-Schools Study Group
- 1Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, Geneva, Switzerland
- 2Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 3Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland
- 4Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland
- 5Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, Geneva, Switzerland
- 6Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, USA
- 7Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 8Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
- 9Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, Geneva, Switzerland
- 10Division of Primary Care, Geneva University Hospitals, Geneva, Switzerland
- 11Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland
- 12University Center for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland
- ↵*Corresponding author information:
Dr Elsa Lorthe, Unit of Population Epidemiology, Chemin Thury 3B, 1206 Geneva, Switzerland. elsa.lorthe{at}gmail.com, +4122 305 58 61
Posted November 24, 2021.
Epidemiological, virological and serological investigation into a SARS-CoV-2 outbreak (Alpha variant) in a primary school: a prospective longitudinal study
